MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-24-0073601
Dominant Pharma Private Limited
Dominant Pharma Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.08 Cr
▲ 21% YoY
Net profit · FY 2025
₹2.48 Lakh
Net margin 2.3%
EBITDA · FY 2025
₹4.51 Lakh
EBITDA margin 4.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8.4 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
About Dominant Pharma Private Limited
Data last updated:
Dominant Pharma Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2013PTC073315. Its GSTIN is 24AAECD5148H1ZS (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hudka Ripal Vrajlal and Umesh Karshanbhai Mendapara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 210 C – 1 Lotus Aura – 2 Opp Lileriya Party Plot Sama Savali Main Road, Vadodara, Gujarat, India – 390008.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹2.48 Lakh (net margin 2.3%) and EBITDA of ₹4.51 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹8.4 Lakh on record.
Dominant Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0073601). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239GJ2013PTC073315
Registration Number 073315
Incorporation Date 09 January 2013
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-24-0073601
Recognitions & Rankings of Dominant Pharma
Contact details
Dominant Pharma Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address210 C – 1 Lotus Aura – 2 Opp Lileriya Party Plot Sama Savali Main Road, Vadodara, Gujarat, India – 390008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dominant Pharma Private Limited, buy the company report.
Comprehensive company report
Dominant Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dominant Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dominant Pharma Private Limited, buy the company report.
Financials of Dominant Pharma Private Limited
FY 2025 filings availableDominant Pharma Private Limited reported revenue of ₹1.08 Cr (up 21% YoY) for FY 2025.
Revenue · FY 2025
₹1.08 Cr ▲ 21%
Net profit · FY 2025
₹2.48 Lakh margin 2.3%
EBITDA · FY 2025
₹4.51 Lakh margin 4.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 19%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 1%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 21% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dominant Pharma Private Limited, buy the company report.
Board of directors of Dominant Pharma Private Limited
Dominant Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hudka Ripal Vrajlal | Director | 09 Jan 2013 | 13 Years 9 Months | Current |
| Umesh Karshanbhai Mendapara | Director | 10 Feb 2016 | 10 Years 8 Months | Current |
Auditor
Dominant Pharma Private Limited is audited by R G BHIMANI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R G BHIMANI & CO | FY 2020 | 127676W |
Shareholding
The shareholding of Dominant Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Dominant Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.4 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jul 2020 | 100352391 | State Bank of India | ₹8.4 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dominant Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dominant Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dominant Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECD5148H1ZS | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dominant Pharma Private Limited, buy the company report.
Recent activity
Dominant Pharma Private Limited has 6 board changes on record since 2013: 2 appointments and 4 cessations. The latest: Avinasbhai Hareshkumar Pandya ceased to be Director on 10 Nov 2016.
AGM
Dominant Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dominant Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with State Bank Of India amounted to Rs. 8.40 Lakh with Charge ID 100352391 was registered on 27 Jul 2020.
Ceased
Avinasbhai Hareshkumar Pandya ceased to be Director.
Ceased
Divyeshkumar Chandubhai Vachhani ceased to be Director.
Ceased
Maheshbhai Manjibhai Vadher ceased to be Director.
Ceased
Umesh Karshanbhai Mendapara ceased to be Additional Director.
Appointed
Umesh Karshanbhai Mendapara was appointed as Director.
Appointed
Hudka Ripal Vrajlal was appointed as Director.
Incorporation
09 Jan 2013
Dominant Pharma Private Limited was registered on 09 Jan 2013 with Roc Ahmedabad & aged 13 years 9 months as per MCA records.
Frequently asked questions
Dominant Pharma is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2013 (13+ years old) and is registered under CIN U24239GJ2013PTC073315.
Dominant Pharma has 2 current directors:
- Hudka Ripal Vrajlal - Director
- Umesh Karshanbhai Mendapara - Director
The latest financial statements of Dominant Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dominant Pharma is 24AAECD5148H1ZS, registered in Gujarat.
The CIN (Corporate Identification Number) of Dominant Pharma is U24239GJ2013PTC073315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dominant Pharma was incorporated on 09 January 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Avinasbhai Hareshkumar Pandya ceased to be Director on 10 Nov 2016. Divyeshkumar Chandubhai Vachhani ceased to be Director on 10 Nov 2016. Maheshbhai Manjibhai Vadher ceased to be Director on 01 Apr 2016. Dominant Pharma has 6 board changes on record in total.
Yes, Dominant Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0073601).
The registered office of Dominant Pharma is at 210 C – 1 Lotus Aura – 2 Opp Lileriya Party Plot Sama Savali Main Road, Vadodara, Gujarat, India – 390008.
Dominant Pharma operates in the pharma industry, in the drug formulation and development segment.